Secondary Malignant Neoplasm — Trials

Secondary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,275
Recruiting: 2,321
Ph III recruiting: 272
Growth YoY: +12.3%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,961)

clinicaltrialsPublishedShowing 301–350 of 2,851 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07148830	Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.(TMpE)	recruiting	N/A	100	Minia UniversityOTHER	1	Sep 11, 2026	clinicaltrials
NCT07161388	Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China(DREAM)	recruiting	—	200	AstraZenecaINDUSTRY	1	Sep 11, 2026	clinicaltrials